CD34 and metastatic neoplasm: Similarly, in animals treated with hepatic RFA alone, metastatic tumors demonstrated increased cellular proliferation (Ki-67) and microvascular density (CD34) compared to sham, sham plus atorvastatin, and RFA plus atorvastatin (p-value <0.001, all comparisons).